Problems with stopping rules in the trials of risky therapies: the case of warfarin to prevent stroke in atrial fibrillation. [electronic resource]
- Clinical research Oct 1993
- 482-6 p. digital
Publication Type: Journal Article
0009-9279
Atrial Fibrillation--drug therapy Cerebrovascular Disorders--prevention & control Humans Randomized Controlled Trials as Topic--standards Therapeutic Human Experimentation Warfarin--therapeutic use